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ABSTRACT

CLINICAL TEST VERSUS SELF-TEST FOR PREDIABETES: OUTCOMES
IN DIABETES PREVENTION BASED ON MODE OF DIAGNOSIS
by
Debra J. Rich
May 2021

Approximately 34.2 million U.S. adults were diagnosed with type 2 diabetes in 2018 and
diabetes prevalence is projected to reach 60.6 million by 2060. A predicted 88 million adults
have prediabetes, but only 15.3% have been diagnosed by a medical provider. Approximately
15-30% of the population with prediabetes will develop diabetes within 5 years without lifestyle
modification to decrease risk. Reduced incidence of diabetes is an urgent priority for Healthy
People 2030 and increased participation in lifestyle change programs is a primary objective. The
Diabetes Prevention Program promotes behavior modification to prevent or delay diabetes.
Despite evidence to support effective intervention, many individuals with prediabetes do not
engage in behavior modification to lower their risk; therefore, it is critical to understand the
factors that influence individual motivation to engage in risk reduction behaviors. A prediabetes
diagnosis based on a clinical blood test or self-risk assessment is required for enrollment in the
program and thus, the purpose of this study is to examine whether participants who completed
the program have different outcomes based on their mode of diagnosis of prediabetes.
This research used archival data from participants (N =793) in Diabetes Prevention
Programming, 46.7% (n = 370) reported clinical testing and 53.3% (n = 423) completed a selftest for program enrollment. A quantitative non-experimental cross-sectional design was
iii

conducted to explore the association between mode of diagnosis—clinical blood test or self-risk
assessment on outcomes of attendance, physical activity, and weight loss in a diabetes prevention
program. Results for the measures of attendance, physical activity, and measures of goal
completion outcomes indicate significant results that reject the null hypothesis that there is no
difference in outcomes between the two sample groups. The study measures for percentage of
weight loss were not significant and failed to reject the null hypothesis. Increased understanding
of the mechanisms by which diagnosis method may impact outcomes could be used to inform
screening procedures and policies as well as communication strategies for participation. The
results may influence physician attitudes regarding patient self-assessment and provide new
opportunity to analyze outcomes of diabetes prevention programming on population health.
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CHAPTER I
INTRODUCTION
Problem Statement
Diabetes mellitus, referred to as type 2 diabetes or diabetes, is a commonly known,
irreversible, chronic disease approaching epidemic proportions in the United States (U.S.).
Approximately 34.2 million adults in the U.S. were diagnosed with type 2 diabetes as of 2018
and an additional 7.3 million people have it but have not been diagnosed by a medical
professional (Centers for Disease Control and Prevention [CDC], 2020a, 2020b). Adverse health
conditions of diabetes are the result of excess blood glucose that damages blood vessels and
severely increases risk for morbidities like stroke, cardiovascular disease, and renal (kidney)
disease, as well as nerve, tissue, and eye damage. A medical status known as prediabetes
proceeds the development of diabetes; it is a serious (but reversible) health condition that
indicates a high risk for developing diabetes. Approximately 88 million—or 1 in 3—adults in the
U.S. have this condition, but only a small amount (15.3%) report that a health professional told
them that they have prediabetes and may be at risk (CDC, 2020a, 2020c). Approximately 1530% of the population with prediabetes will develop type 2 diabetes within 5 years if they do not
engage in lifestyle modification or interventions to decrease their risk. Behavior modification to
prevent diabetes can improve health, reduce the incidence of diabetes and its associated
complications, and save substantial medical costs (Institute for Clinical and Economic Review
[ICER], 2016).
Despite general awareness of the health threat associated with diabetes and evidence to
support effective intervention at the prediabetes stage, many individuals with prediabetes do not
make or sustain modifications to behavior that will lower their risk (Paige et al., 2017; Warner,
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2009). To minimize incidence and prevalence of type 2 diabetes in the U.S., it is critical to
understand the factors that influence individual motivation to engage in risk reduction behaviors.
Background
Diabetes is a disease caused by elevated blood glucose levels and type 2 diabetes is the
most common subtype. There is an increased risk of chronic health conditions, disease, and
disability for people with diabetes and they die an average of 4.6 years earlier than people who
are non-diabetic (Bardenheier et al., 2016; CDC, 2020a). Diabetes was the seventh leading cause
of death in the U.S. in 2017 (CDC, 2020b). The direct and indirect costs associated with diabetes
care in 2017 were approximately $327 billion and individuals with diagnosed diabetes have
average medical cost up to 2.3 times higher than non-diabetic patients (American Diabetes
Association [ADA], 2018; CDC, 2018a).
Diabetes Prevalence
Although 34.2 million adults in the U.S. were diagnosed with diabetes in 2018, an
estimated 7.3 million people are undiagnosed, and 1 in 6 adults will develop diabetes by the year
2060 (CDC, 2020a, 2020c; Lin et al., 2018). Reduction of diabetes cases is an urgent priority for
Healthy People 2030 (HP2030) and increased participation in lifestyle change programs is a key
objective to lessen diabetes incidence (Healthy People [HP], 2020). Reduction of the incidence
rate could lower the diabetes prevalence by 5 million within 10 years (Lin et al., 2018).
Prediabetes
Prior to developing diabetes, individuals have prediabetes, which is defined as a
condition where blood glucose levels are elevated more than normal and the higher level can be
detected through clinical testing. Individuals who are overweight, have a sedentary lifestyle, and
a family history of diabetes are at higher risk for prediabetes along with women who experience
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gestational diabetes and some racial and ethnic identities. Approximately 88 million U.S. adults
over 18 had prediabetes in 2018, but only a small portion (15.3%) received a clinical diagnosis
from a medical professional regarding their condition (CDC, 2020c). A person’s increased risk
for prediabetes may be identified by either a self-risk assessment test or by a clinical diagnosis
determined by a medical professional based on results from blood glucose tests. Health care
professionals and health organizations use different methods to identify, diagnose, and treat
prediabetes. Health care providers may choose to monitor patient glucose levels over time rather
than recommend a lifestyle modification program for diabetes prevention. Most individuals with
prediabetes will eventually develop diabetes—some within 5 years—if they do not engage in
lifestyle modification or interventions to decrease their risk (ICER, 2016; Tuso, 2014).
National Diabetes Prevention Program
Clinical trials have determined that weight loss and increased physical activity are
effective ways to reduce risk for diabetes (Ely et al, 2017; Knowler et al., 2002). The Diabetes
Prevention Program (DDP) is a one-year behavior modification class that has been successful in
helping individuals prevent or delay diabetes (Knowler et al., 2002). Participants qualify for the
program with either a clinical blood test of prediabetes or by completing an evidence-based
diabetes risk assessment. Certified lifestyle coaches facilitate the DPP in weekly group sessions
using a theory-based curriculum that supports positive lifestyle change through group interaction,
skill-building, positive affirmation, and goal setting. Less than half of the participants who
register for DPP complete the program and attrition is highest after the first session, which could
be attributed to lack of motivation toward behavior change (Cannon et al., 2020; Ely et al.,
2017).
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The Use of Theory in Behavior Change
Health behavior theories identify factors that influence a person’s behavior and provide a
framework for intervention and health improvement. The Social Cogitative Theory (Bandura,
1986) is based on a model of environmental factors, individual behavior, and personal factors
that intersect to influence individual health-related behaviors. This framework was used to
develop the DPP curriculum and the session topics, interactive learning opportunities, and
personal goal setting activities all serve to influence positive health behavior change. Theories
such as the Transtheoretical Model of Change, Health Belief Model, Theory of Reasoned Action,
and Theory of Planned Behavior are used to identify and explain specific factors that may
influence a person to move towards adoption of new behavior. Once a person engages in
behavior change, these factors may also influence their ability to successfully achieve the
expected outcome(s) from the new behavior. Therefore, examination and application of theory
constructs can be used to consider whether the method of diagnosis for prediabetes may
influence participant outcomes due to behavior change in a DPP.
Implications for Research
The implications for this research are multifaceted and varied, regardless of whether the
diagnosis method demonstrates a salient factor in participant outcomes from the prevention
program. The upward trend of diabetes incidence and prevalence continues to drive healthcare
needs and associated costs towards tertiary treatment of diabetes and related complications. If
healthcare expenses and overhead are focused on disease management, it may jeopardize the
organizational ability to promote and sustain effective prevention programming. An association
between mode of prediabetes diagnosis and DPP outcomes could further inform the use of health
behavior theory constructs as opportunity for intervention in program planning. An increased
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understanding of the mechanisms by which diagnosis method may impact DPP outcomes may be
used to inform screening procedures and policies as well as recruitment and retention
communication. Thus, the research aim of this study is to explore the association between mode
of prediabetes diagnosis— clinical blood test or self-risk assessment— on measured DPP
outcomes of attendance, physical activity minutes, and percentage of weight loss. A theoretical
application supports the directional hypothesis.
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CHAPTER II
LITERATURE REVIEW
Diabetes in the United States
The purpose of this section is to illustrate the magnitude of diabetes as a major health
concern and provide background information to support the importance of intervention tactics to
reduce the incidence of disease. Diabetes is a metabolic disease related to elevated blood glucose
levels. Increased blood glucose is the result of either defective insulin secretion (type 1 diabetes),
or ability to effectively use insulin in the body (type 2 diabetes). Gestational diabetes (GMD)
occurs when pregnancy hormones inhibit effective insulin use, resulting in insulin resistance and
elevated blood glucose. Type 2 diabetes (indicted hereafter as diabetes) is the most common
subtype of diabetes, accounting for approximately 90-95% of all diagnosed cases of adult
diabetes (CDC, 2020a, 2020b, 2020c; Sapra & Bhandari, 2020).
Diabetes Impact on Health
When the body does not process excess glucose effectively, blood sugar levels increase,
damage blood vessels, and may severely increase risk for developing life-threatening morbidities
(ADA, 2020a). People with diabetes often develop additional risk factors for disease like above
normal cholesterol, triglycerides, and/or blood pressure levels. Evidence shows that diabetes has
been linked to an increased risk of developing stroke, heart disease, or kidney failure, and
outcomes of blindness, amputations of lower extremities, development of dementia and
Alzheimer’s disease, and increased risk for disability and premature death (CDC, 2020a; Dolan
et al., 2018; Giovannucci et al., 2010). Disability may develop up to 7 years earlier in adults with
diabetes and as a result, experience more years in a disabled state than those without diabetes.
Bardenheier and colleagues (2016) indicate men diagnosed with diabetes spend 20-24% of their
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remaining life disabled and report similar associations for women. An additional 1 to 2 years
spent in a disabled state may severely impact quality of life for people with diabetes (CDC,
2020a, 2020c; Bardenheier et al., 2016). In 2017, over 83,500 death certificates indicated
diabetes as the cause of death in the U.S., making it the seventh leading cause of death (crude
rate 25.7 per 100,000). Over 270,702 death certificates listed diabetes as contributing to or
underlying the cause of death (CDC, 2020b). Individuals with diabetes die 4.6 years earlier and
have 60% higher risk of premature death than people who are non-diabetic (Bardenheier et al.,
2016).
Financial Impact of Diabetes
The American Diabetes Association (ADA) states that diabetes is a substantial economic
burden on society. In the U.S., approximately $327 billion was spent on direct ($237) and
indirect ($90) costs related to diagnosed diabetes in 2017; this was an increase of 26% in
economic costs over the prior 5 years (ADA, 2018). Excess medical costs associated with
diabetes increased between 2012 and 2017 from $8,417 to $9,601 per person. Indirect costs are
not associated with the direct treatment of disease but they have a financial effect on society.
Diabetes-related indirect costs include work absenteeism, less productivity due to disability or
health conditions, and premature mortality. Direct medical costs include the increased cost of
medical care that persons with diabetes often incur. People with diagnosed diabetes have average
medical care costs of $16,750 annually, with $9,600 attributed to direct medical costs of
diabetes. The increased average medical cost may be up to 2.3 times higher than non-diabetic
patients due to health conditions related to diabetes and increased need for hospital services
(ADA, 2018; CDC, 2018a).
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Diabetes Distribution
Over 34.2 million adults in the U.S. in 2018 were diagnosed with diabetes and an
estimated 7.3 million more were undiagnosed. The number of diagnosed persons is projected to
reach 60.6 million (>1 in 6 adults) by 2060 (CDC, 2020a, 2020c; Lin et al., 2018). Prevalence of
diabetes increased steadily from 1999 through 2016 for both men and women as well as all age
groups, education levels, and racial and ethnic groups. A portion of the projected prevalence
rates is assumed due to improvements in health care and diabetes self-management or lifestyle
changes that result in people living longer with diabetes. Despite a decrease in the incidence rate
for adults in the past ten years, there has been an upward trend in the rate among adolescents and
children, as well as increased complications related to diabetes in younger adults aged 18-44
(CDC, 2020a, 2020b, 2020c; Lin et al., 2018). Slowing the incidence of diabetes has become an
urgent priority. A reduction in the number of diagnosed diabetes cases each year is one of the
Leading Health Indicator (LHIs) for health improvement and wellbeing by Healthy People 2030
(HP2030). The LHI goal is 5.6 new cases of diabetes per 1,000 adults aged 18 to 84 years; a
reduction of 1 new case per 1,000 over cases reported in 2016-2018. One objective to achieve
this goal is increased participation in lifestyle change programs (Healthy People, 2020). Analysis
predicts a 20% reduction in the incidence rate of diabetes will reduce the diabetes prevalence by
5 million in 2030, and 10 million in 2060 (Lin et al., 2018).
Contributing Factors for Diabetes
Many of the risk factors for diabetes-related complications are behavior-related outcomes
that may have contributed to development of the disease. Physical inactivity and smoking are
common factors for hypertension, increased cholesterol measures, and overweight/obesity (CDC,
2020b). Diabetes may go undiagnosed until a person experiences health complications such as
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fatigue, blurred vision, frequent urination, or increased hunger and thirst. People who develop
diabetes go through a prediabetes status where rising blood glucose levels indicate an increase in
risk before development of the disease. Because there is no known cure, and medical treatment
cannot prevent most of the health complications that are associated with it, prevention is the
preferred medical action for diabetes. Medical professionals have an opportunity to help patients
achieve diabetes prevention if they intervene at the prediabetes stage (Tuso, 2014). This
opportunity for intervention may be complicated by a lack of standard protocol and procedures
for routine screening and perceptions of services available for prevention.
Prediabetes Status
This section describes the physical state that precedes onset of diabetes and explains how
the pre-disease state provides opportunity to lower risk of diabetes. Prediabetes is a reversible
medical status where blood glucose levels are higher than what is considered normal, but not
high enough to be classified as diabetes. Several tests are used to determine whether a person’s
blood glucose is above normal levels. A fasting plasma glucose (FPG) test measures blood sugar
after fasting overnight and a level of 100 to 125 mg/dL indicates prediabetes in the U.S. The oral
glucose tolerance test (OGTT) is also conducted after an overnight fast, and measures a person’s
blood sugar before and after consumption of liquid glucose. Blood levels are checked at 1 and 2
hours, and prediabetes is determined if the levels are 140 to 200 mg/dL. The Hemoglobin A1c
(A1c) test measures glucose levels in blood cells over time, usually 90 days; a score between 5.76.4% indicates prediabetes. Approximately 50.0% of women with GDM eventually develop
diabetes and are generally considered to be at risk of prediabetes (CDC, 2020c).
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Prediabetes Distribution
In 2018, approximately 88 million (34.5%) of U.S. adults aged 18 years or older had
prediabetes, but only 15.3% were aware of their condition through a clinical diagnosis from a
health professional (CDC, 2020c). Approximately 35 million adults with prediabetes are 45 to 64
years of age and 24 million are 65 years and older; however, the prevalence of prediabetes in
young adults and adolescents in the U.S. has increased (CDC, 2020a). A 2005–2016 study found
that 1 in 5 adolescents (18.0%) and 1 in 4 young adults (24.0%) had been diagnosed with
prediabetes (Andes et al., 2019). Prevalence of prediabetes was similar among all racial/ethnic
groups and education levels; however, a higher percentage of men (37.4%) than women (29.2%)
had prediabetes based on age-adjusted data for U.S. adults aged 18 years or older 2013–2016
(CDC, 2020b). An estimated 15-30% of individuals with prediabetes will develop diabetes
within 5 years, and up to 70% of individuals with prediabetes will eventually have diabetes if
they do not engage in lifestyle modification or interventions to decrease risk (Institute for
Clinical and Economic Review [ICER], 2016; Tuso, 2014).
Prediabetes Impact on Health
The measure of risk for developing diabetes is closely associated with an individual’s
A1c or FPG levels when they are diagnosed. If patient levels are in the higher range, with A1c
near 6.4%, and FPG near 125 mg/dl, they are more likely to develop diabetes. A1c numbers
closer to 5.7% and FPG numbers closer to 100 mg/dl are more likely to maintain or lower their
glucose levels to a normal range although this likelihood may be impacted by the patient’s level
of insulin production and age at the time of diagnosis (CDC, 2020c; The diaTribe Foundation,
n.d.).
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In addition to increasing the risk of developing diabetes, evidence suggests that higher
than normal blood glucose levels may result in above normal cholesterol, triglycerides, and/or
blood pressure levels as well as kidney and nerve damage at the prediabetes stage (CDC, 2020a;
Tabák et al., 2012).
Contributing Factors for Prediabetes
Family history, genetics, and a combination of lifestyle factors (food choices, sedentary
lifestyle, stress levels, and sleep disturbances) may contribute to development of prediabetes, yet
it is often simply the result of being overweight or obese. The prevalence of prediabetes for
individuals with normal weight is 28%, and it increases to 36% for overweight, and 40% for
those considered obese. Overweight/obese is a contributing factor for insulin resistance, but not
all overweight individuals develop prediabetes or diabetes, and there are a minority of
individuals with prediabetes who are not overweight (The diaTribe Foundation, n.d.). The
ADA/CDC Prediabetes Risk Test (Figure 1) is used to indicate a likelihood of prediabetes status
based on answers to questions related to risk factors for diabetes. The assessment surveys
whether the individual is 45 years or older, overweight, physically active less than 3 times a
week, and asks if they have a family member (parent or sibling) with diabetes. Women are asked
to indicate if they had gestational diabetes, or gave birth to an infant weighing 9 pounds or more.
Racial and ethnic identity demographics are also considered as African Americans, Hispanics,
American Indians, and some Pacific Islanders and Asian Americans experience higher risk for
diabetes than Caucasian identity. Individuals with scores that indicate increased risk are
encouraged to talk to a medical provider to see if additional testing is needed to determine
whether they have a higher risk for diabetes (CDC, 2020d; ADA, 2020a).
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Clinical Diagnosis and Referral for Prediabetes
The information in this section is to expand on the role of health professionals in the
diagnosis of patient diabetes risk and offer insight regarding barriers to intervention and
prevention tactics. The clinical definition of prediabetes is a source of controversy and varies
among health care professionals and health organizations. The World Health Organization
(WHO) defines prediabetes with the criteria of an FPG of 110-125 as well as an oral glucose
tolerance test (OGTT) of 140 to 200 mg/dL. The ADA criteria are the same for OGTT, but the
FPG test has a lower value of 100-125 mg/dL to define prediabetes. In addition, the U.S. criteria
use an A1c measure of 5.7% to 6.4% to indicate prediabetes (ADA,2020c; Barry et al, 2018).
Clinical diagnosis of prediabetes in the U.S. usually starts with the FPG, then progresses to an
OGTT test to confirm results. An A1C test may be preferred by providers because it does not
require fasting or extended lab visits. A1c test ideally represents a person’s average glucose level
over 90 days, rather than a single point in time like the FPG and OGTT. However, certain
genetic traits, separate from blood glucose, are known to substantially impact A1c levels and
may make this an inaccurate measure for the total population (Bansal, 2015).
Potential to Impact Patient Health
Assessment of knowledge regarding prediabetes screening standards among primary care
providers (PCP) revealed that only 6% were able to correctly identify the risk factors that
indicate a need for screening for prediabetes and only 17% knew the fasting glucose and A1c
laboratory parameters used for diagnosing prediabetes (Tseng et al., 2017). The survey
participant responses indicated gaps in their knowledge related to ADA recommendations for
lifestyle modifications to decrease risk of diabetes. Professional organizations that provide
guidance to PCP’s do not include prediabetes in their best practice guidelines and this may factor
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in their lack of knowledge (Tseng et al., 2017). Results of a survey of self-reported prediabetes
screening, testing, and referral among 1256 PCP’s indicated that 97% of the providers tested for
prediabetes with one of the ADA recommended blood glucose tests. One-third (27%) of the
providers used the ADA/CDC Prediabetes Risk Test (Figure 1) and only 23% referred their
patients to attend CDC-recognized LSM classes (Nhim et al., 2018). These results are consistent
with the findings in a survey of family physicians (n 1248) to measure attitudes towards
prediabetes and screening. Most physicians used blood glucose as their screening method for
prediabetes (Mainous et al., 2016). A little more than half (52.4%) indicated that they followed
the national guidelines for diagnosis, and one-third reported uncertainty regarding whether their
patient care and screening was consistent with recommended guidelines.
Factors That Influence Prediabetes Screening and Intervention
The survey of family physicians (2016) revealed that physicians often perceived barriers
to prediabetes treatment on their patient’s behalf, including economic challenges (71.9%), ability
to sustain motivation (83.2%), and the patient’s ability to modify their lifestyle (75.3%).
Seventy-five percent of those surveyed indicated that adequate time to educate patients regarding
diabetes was a barrier to prevention methods (Mainous et al., 2016).
Analyses of 2016-2017 National Health Interview Survey (NHIS) data of adults with
diagnosed prediabetes revealed 73.5% (95% CI, 71.6.5%-75.3%) reported their medical provider
gave them advice or referral for behavior modification after their clinical diagnosis of
prediabetes; however, only 35% (95% CI, 30.5%-39.8%) reported engagement in the
recommended modification within a year of their diagnosis (Ali et al., 2019). Adults with risk
factors of higher-than-normal BMI and ADA/CDC risk scores, but without a clinical diagnosis of
prediabetes reported that only 50.6% (95% CI, 49.5%-51.8) received any risk-reduction advice
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or referral from their medical provider and only 33.5% (95% CI, 30.5%-39.8%) reported
engagement in the recommended modification within a year of receiving the advice.
Participation in LSM programs to prevent diabetes was low for both groups; only 4.9%
(95% CI, 4.1%-6%) of those diagnosed with prediabetes and less than 1% (0.4%; 95% CI, 0.3%0.5%) of adults at risk received referral or advice to engage in LSM program for diabetes
prevention (Ali et al., 2019; Venkataramani, et al., 2018). Health care professionals gave general
physical activity or dietary recommendations 2 to 3 times more often than they referred patients
to formal behavior modification programs (Ali et al., 2019).
National Diabetes Prevention Program
This section introduces the specifics of the nationally funded program developed in
response to the rising incidence of diabetes in the United States. The origin of the NDPP is a
randomized, clinical trial sponsored by the National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK). The research aim was to determine if certain interventions could
prevent or delay diabetes in adults with blood glucose levels that were higher than normal, but
not diagnosed as having diabetes (Knowler et al., 2002). Research confirmed that minimal
weight reductions of 5%-7% achieved through lifestyle modification, dietary changes, and
increased physical activity of at least 150 minutes per week were effective in 58% (95% CI 4866) reduction of incidence of diabetes (Ely et al, 2017; Knowler et al., 2002).
The Diabetes Prevention Program Outcomes Study (DPPOS) analyzed whether the
results of the DPP trial would result in long-term diabetes risk reduction. Eighty-eight percent of
the (surviving) individuals from the 1996-2001 DPP trial enrolled in the ten-year follow-up
outcome study. Results of the DPPOS study showed that modest weight loss resulting from
intensive lifestyle changes reduced risk of developing diabetes by 34% (compared with placebo)
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and 49% in those over age 60 (National Association of Chronic Disease Directors [NACDD],
n.d.; National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK], 2002).
National Diabetes Prevention Program Impact on Health
The U.S. Congress authorized the CDC to develop NDDP infrastructure to support
evidence-based, cost-effective intervention programs as a public/private partnership with
qualified organizations in the U.S. (CDC, 2020e). In 2012, six national organizations—
including the YMCA of the U.S.— received funding to implement the DPP across multiple states
over a 4-year timeframe. The goal was to test whether the prevention program offered in a group
setting would result in long-term diabetes risk reduction in a community setting. Nearly 15,000
participants were enrolled in the 165 sites established during the four years and program data
was used to create best practice models for program delivery that are used today (Nhim et al.,
2019).
In 2016, the Centers for Medicare and Medicaid Services (CMS) approved the national
DPP program as a cost-saving, patient care improvement model. It then received certification as
a preventative service model for expansion by The Department of Health and Human Services
(HHS) and the Medicare Diabetes Prevention Program (MDPP) was made available to
beneficiaries in 2018. As of December 2019, 185 organizations had enrolled as MDPP suppliers
for program delivery in 760 locations, and 11 states had elected to include the NDPP as a health
benefit for Medicaid beneficiaries (CDC, 2020a). These critical policy expansions were a step
towards reducing diabetes incidence in the estimated 46.6% of seniors with prediabetes, as well
as influence insurance industry standards and private coverage of DPP. (CDC, 2020b; Ely et al.,
2017).
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Diabetes Prevention Programming Delivery
To ensure fidelity of evidence collected from program delivery organizations, the CDC
also established the Diabetes Prevention Recognition Program (DPRP) (CDC, 2019). To achieve
recognition, organizations must use the NDDP curriculum (or approved adaptation) and ensure
lifestyle coaches are trained in facilitation to support the theoretical concepts. Because the
program was developed for persons known to be at risk for developing diabetes, a minimum of
35% of participants in a year-long program must be eligible for enrollment based on a clinical
blood test determining prediabetes or a history of GDM. The remaining participants (65%
maximum) must be eligible based on the ADA/CDC Prediabetes Risk Test (Figure 1) (CDC,
2018b; Ely et al., 2017). Recognized programs are required to submit annual data on participant
attendance, weight, and duration of physical activity in minutes, which are used by CDC to
assess program impact on preventing or delaying the onset of diabetes (CDC, 2019; ICER,
2016). According to the national registry of CDC-recognized diabetes prevention programs,
there are approximately 1800 CDC-approved LSM programs in the U.S. (CDC, 2020f).
Yakima County Diabetes Prevention Programs
Washington State has over 50 CDC-recognized program locations (CDC, 2020f). Three
programs—Yakama Indian Health Service, Yakama Nation Wak’ishwi Program, and Virginia
Mason Memorial (VMM)—are located in Yakima County; the geographical location of this
study (CDC, 2020f). Yakima Valley Memorial Hospital, a rural nonprofit hospital system
(operating as VMM during the study period), implemented English and Spanish diabetes
prevention programming in 2013 in partnership with YMCA of Yakima as part of the national
expansion of NDDP (Nhim et al., 2019; Virginia Mason Memorial [VMM], 2020). The VMM
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program received official recognition status in 2017 and has provided LSM programming to
approximately 1400 participants through 2020.
DPP has been widely promoted within the Central Washington region through paid
advertisement, direct mail, social media, news coverage, and patient education materials
distributed at medical and health clinics. Community health educators meet frequently with
providers associated with VMM to distribute program materials, share data outcomes, and
streamline the process for patient referral to the program. VMM also participates in many
community health and wellness events in Yakima County, offering fasting blood glucose
screening and consultation along with education for health improvement that may include
referral to DPP (VMM, 2020).
The VMM program requires attendance at a community orientation meeting or 1:1
counsel with the program coordinator before enrollment in DPP. Orientation attendees receive
diabetes prevention educational materials, view or hear testimonials from former participants,
and those without a clinical diagnosis of prediabetes are encouraged to complete the ADA/CDC
Prediabetes Screening Test (Figure 1) to determine their risk of developing diabetes. VMM
estimates that 99% of attendees who attend the orientation enroll in the program within two
months (VMM, 2020).
Elements of Diabetes Prevention Programming
The requirements for enrollment in DPP include adult 18+, overweight, BMI ≥ 24 (≥ 22,
if Asian), non-pregnant, and have not been diagnosed with type 1 or type 2 diabetes. Participants
must have a diagnosis of prediabetes based on a clinical blood test, a previous diagnosis of
GDM, or complete an evidence-based diabetes risk assessment (Figure 1). Enrollees in a
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program covered by Medicare must have had a recent clinical blood test indicating prediabetes
(CDC, 2020e).
The DPP curriculum is delivered by certified lifestyle coach/facilitators in a group
environment of approximately 18 to 20 people. The structure of the 1-year program consists of
16 weekly 1-hour core sessions, 2 bi-monthly post-core sessions, then 4 monthly post-core
sessions. Facilitators weigh and record the participant weight measures before each session and
collect participant-reported measures of physical activity minutes starting in week 6. Participants
are encouraged to attend every session and track their progress towards the program outcome
goals of 5%-7% weight loss and 150 physical activity minutes per week (CDC, 2020e).
The curriculum used in the original clinical trial was developed and written at the
University of Pittsburgh by the DPP Lifestyle Resource Core (University of Pittsburg, 2021).
The Diabetes Training and Technical Assistance Center was established in 2009, at Emory
University’s Rollins School of Public Health to adapt the curriculum for delivery in a group
format and create a training certification program for lifestyle coaches (Emory University, 2020).
The lifestyle change curriculum is based on the Social Cognitive Theory (SCT) developed by
Bandura (1986), who theorized a reciprocal relationship and determinism between a person’s
behavior, cognitive thoughts and abilities, and their environment. Six major constructs influence
behavior within the SCT; outcome expectations and expectancies, behavioral capability, selfefficacy, the environment, and the perceived behavior of others (Bartholomew et al., 2020;
DiClemente et al., 2013; Rimer, et al., 2005). Lifestyle coaches are certified in curriculum
delivery that reinforces the SCT constructs and they support participants with weekly feedback
to guide healthy eating decisions while forming new health behavior habits. Participants learn
about positive lifestyle change through interactive lessons in food and nutrition management,
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participate in group sharing and knowledge interaction, and set outcome goals based on their
individual health needs. As participants achieve their goals, they build confidence in their ability
to change behavior and model that behavior within their group and social environment. The
group format and interactive learning environment encourage ongoing program attendance which
is considered a best practice for attaining the goal outcome goals for the program. (Baker et al.,
2011; CDC, 2018b; 2018c).
Diabetes Prevention Program Results
Participants who attend more than 17 DPP sessions and report >150 minutes of physical
activity per week show median weight-loss rates of 6%, and weight loss of 0.31% (p <0.0001)
for every additional session attended, as well as an additional 0.3% (p <0.0001) for every 30
minutes of physical activity reported by participants per week (Ely et al., 2017). Alva (2019)
measured attendance among Medicare beneficiaries enrolled in DPP and compared the findings
with claims data to determine the impact of attendance on weight loss and medical costs. The
mean attendance was 14 (SD 6 sessions, 24 max), participants lost an average of .72 lbs. (.67 .77 lbs.) per week, and saved approximately $58 (mean) in medical cost for each session they
attended. Completion of at least 14 sessions is recommended to achieve a weight loss of 5% and
obtain relevant medical cost savings (Alva, 2019).
Evidence shows increased positive outcomes associated with how long the individual is
in the program and significant association with participation beyond the 16 core weekly sessions
and achievement of >5% weight loss (Ely et al., 2017; Jeffers et al., 2019). However, less than
half of the participants (43%) who register for DPP complete the 16-week core curriculum.
Attrition is highest after the first session, which could be attributed to behavior constructs such as
attendees’ understanding of program outcome goals, perception of ability to meet the
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expectations of the program, or their motivation and attitude toward behavior change (Cannon et
al., 2020; Ely et al., 2017).
Health behavior theory is used to understand how constructs such as expectations,
behavioral capability, and self-efficacy (among others) influence engagement and retention in
DPP as well as behaviors prior to participation in health improvement strategies. They can
provide insight regarding the factors that may influence an individual who has been diagnosed
with prediabetes or has completed a self-test to determine their diabetes risk, to move towards
participation in prevention opportunities.
Theoretical Frameworks to Influence Behavior Change and Program Outcomes
The purpose of this section is to describe some of the ways that individuals may move
towards behavior change and illustrate how health improvement programs may benefit from
using application of theory to understand those behaviors. The theoretical frameworks featured
in this section will be applied to understand the ways that the method of diagnosis—clinical test
or self-risk assessment—may influence outcomes attained through a lifestyle management
program such as DPP.
In order to complete this analysis and application of theory, some assumptions have been
determined that generalize the knowledge, experience, and expectations of individuals prior to
their participation in DPP. (Enrollment in the program requires either a clinical diagnosis of
prediabetes or a self-risk assessment that confirms a person’s risk of developing diabetes.) If a
person has received a clinical diagnosis of prediabetes it could be presumed that they were
unaware of their condition prior to diagnosis and their initial perception would be influenced by
the attitude, perceptions, and knowledge of the provider as it relates to diabetes risk and DPP as a
mechanism for prevention. It may also be assumed that they are in a state of receiving
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information rather than actively seeking a diagnosis. It is the expectation that the individual has a
professional relationship with their provider and that they will have contact with the provider
during or after they participate in the program.
The self-risk assessment has been extensively promoted through health improvement
outreach at a national and local level and was also provided at monthly orientation sessions
hosted by the DPP coordinator. If an individual completes a risk test as a prerequisite to
participation in DPP, it could be presumed that they were aware of the prevention program and
have a perception of the value of participation in the program. It could also be assumed that they
are in a state of seeking information. If they completed the test after attending orientation, it
could be assumed that it was their decision to attend the orientation, perhaps with the intention to
enroll, before receiving information about the program. It can be expected that the individual
used critical thinking and honest assessment when they completed the risk test and in a state of
prediabetes.
Health behavior theories consist of key theoretical constructs that influence behavior and
provide a framework for intervention. The constructs may work independently, concurrently, or
in multiple layers and are applied at multiple points along a spectrum of behavior change from
unawareness through behavior maintenance. Theories often share similar constructs although
they are assumed to influence behaviors in different ways depending on when they are applied,
therefore it is important to consider how theory-based curriculum may influence behavior change
outcomes. Program planners often combine multiple theoretical frameworks to understand health
behaviors that result in lack of engagement, guide development of programs, and implement
curriculum to reinforce behavior change and maintenance (DiClemente et al., 2013; Rimer, et al.,
2005). Commonly used health behavior theories include the Theory of Reasoned Action and
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Theory of Planned Behavior, the Health Belief Model, Transtheoretical Model of Change, Social
Cognitive Theory, and Diffusion of Innovation Theory.
Theory of Reasoned Action and Theory of Planned Behavior
Theoretical models like the Theory of Reasoned Action (TRA) and the Theory of
Planned Behavior (TPB) are based on concepts of value expectancy. Individuals form decisions
related to health behavior change based on their perception and measure it in terms of the benefit
versus the cost. A person’s perception of the benefit—what they will achieve by making
behavior change— is measured against a perception of the effort they expect to make towards
that change. These costs (efforts) may be measured by physical, social, emotional, or financial
investment. The benefits may be directly related to health improvement, but they are often
perceived in terms of physical ability or fitness, appearance and weight loss, or increased
adoption of desired social norms such as participation in recreational sports and physical
activities (Ajzen & Fishbein, 1980; DiClemente et al., 2013; Rimer, et al., 2005).
TRA, developed by Ajzen and Fishbein (1980), assumes that a person’s health behavior
belief and their social influences are factors that shape their behavioral intent. The endpoint of
the theory is an intention to perform a particular behavior and the next action will be the desired
behavior. TRA definition of behavioral intention includes a timeframe for the behavior to be
performed, an exact description of the action of the behavior, the outcome that is desired from
the behavior, and the context of the behavior. Behavioral intention is mediated by attitude which
is shaped by individual beliefs and evaluation of outcomes related to the behavior. Subjective
norms also impact intent as they are formed in part by a person’s motivation to comply because
of their perception of what people important to them would think about the behavior (Ajzen &
Fishbein,1980; (DiClemente et al., 2013).
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Ajzen (1988) expanded on the theoretical base of TRA to create the TPB model by
adding a construct of perceived behavioral control. TBP assumes that perception of favorability
towards a behavior, along with subject norms that support it, will influence the likelihood that a
person will perceive control over the behavior. This perception is influenced by a number of
external factors that may serve to either facilitate or inhibit the behavior. The factors that
influence perception are not actualized but are part of evaluation of the value and benefit of
behavior change and they may influence perception without cognitive thought (Ajzen, 1988;
DiClemente et al., 2013).
Theory of Planned Behavior and Current Study. Application of TPB to this research
could align the mode of prediabetes diagnosis as one of the factors that influence attitude, subject
norms, and perceived behavior control toward the behavioral intention to enroll in the DPP.
Other factors that may influence behavioral intent include individual interpretation of
promotional messaging, social interactions with people in the program, and their previous
experiences or knowledge about prediabetes. Since the constructs of TPB applies to the intent to
perform the behavior, the curriculum of the program would build on the factors that influenced
their intention to participate, and could therefore lead to favorable outcomes from the program.
As discussed in the opening paragraph of this section, if a person receives a clinical
diagnosis of prediabetes, their attitude toward behaviors, subject norm, and perceived control
constructs could be influenced in part by the provider who provided the diagnosis. If the provider
shares information about the program in a positive way, the patient may have a more favorable
attitude toward the behavior expected from the program. The provider attitude may also
influence the patient’s perception of normative behavior following a diagnosis of prediabetes if
they recommend enrollment in the DPP. The perception of behavioral control may be dependent
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on their personal understanding of the elements of the DPP along with the knowledge and
attitude of the medical provider towards the program (Mainous et al., 2016; Nhim, et al., 2018).
If a person completes a self-assessment for risk test as a prerequisite to participation in
the DPP, they may be moving toward the TRA definition of behavioral intention as they consider
the behavior timeframe, the behavior action, and desired outcome of the behavior. They may
already have a positive attitude towards the new behavior and perception of their behavioral
control. If they attended the orientation session, their subject norm will likely be influenced by
motivation to comply with the invitation to enroll and also by those in attendance who support a
normative belief and positive attitude towards the behavior.
Health Belief Model
Perception of threat and fear appeal theories build on the construct of value expectancy
by adding perceptions that relate to threat or fear about the probability and severity of negative
health outcomes. The Health Belief Model (HBM), developed by Rosenstock (1974), has been
widely used in public health campaigns to motivate individuals toward behavior change
(DiClemente et al., 2013; Rimer, et al., 2005). The Health Belief Model primary constructs are
perceived susceptibility and severity, and perceived gain (benefit) from the behavior. These
perceptions are influenced by personal moderators such as age, socioeconomic status, and
knowledge about the health threat, as well as cues to action from events, or interventions that
relate to the threat. An updated version of the model includes self-efficacy as an independent
variable for health-related behavioral interventions because most people will not move toward
new behavior unless they feel confident that they are capable of performing the behavior
(Rosenstock, et al., 1988). The model suggests that a person’s motive for change is based on
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their perception of the severity of, and susceptibility to, the health problem (threat), and
perception of gain from behavior change (DiClemente et al., 2013; Glanz & Bishop, 2010).
Health Belief Model and Current Study. Application of HBM to this research
considers how the two different types of prediabetes diagnosis may impact individual
perceptions of susceptibility and severity of disease. A person’s perception and likelihood of
action will also influence their overall perceived threat of disease and therefore factor in the
likelihood of taking preventative action by participating in the DPP. Individuals with either
diagnosis will receive cues to action from promotional messaging and social interactions, as well
as draw on prior knowledge to shape their perception. Their perceived threat of diabetes may be
limited by lack of knowledge of the disease or enhanced by information regarding the finality of
prediabetes progression towards diabetes. Reinforcement of behaviors that reduce risk will have
a positive impact on their self-efficacy and influence the likelihood that they will take
preventative action.
If the person has clinical diagnosis of prediabetes, their perception may be influenced by
the provider who gave the diagnosis. Patients may experience increased perception of
susceptibility and severity of disease due to the tangible element of a clinical test and knowledge
from a medical professional. Personal assessment of disease risk may vary among educational
levels and cause misunderstanding or communication barriers between patients and medical
professionals regarding the risk factors and health threats associated with prediabetes and
diabetes.
If a person completes a self-assessment for risk test as a prerequisite to participation in
the DPP, they may already have a perception of their susceptibility and the severity of disease, as
well as a perceived benefit from engaging in prevention through DPP. If they attended the
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orientation session, their perception of gain from behavior change will likely be influenced by
the testimonial of prior participants and the availability of information to assess risk.
Transtheoretical Model of Change
The Transtheoretical Model of Change (TMC), developed by Prochaska & DiClemente
(1983) has been used to facilitate motive for behavior change in a variety of health promotions
(DiClemente et al., 2013; Glanz & Bishop, 2010; Rimer, et al., 2005). The TMC states that
willingness to engage in a lifestyle change or behavior modification program occurs in stages of
pre-contemplation, contemplation, preparation, action, and maintenance. Individuals may stop or
step back at a particular stage rather than proceed sequentially towards a new health behavior.
The processes of change are techniques or interventions that effectively enhance or promote
movement to the next stage. Early stages of pre-contemplation to contemplation are reliant on
awareness processes to affect change like consciousness-raising, or reevaluation. Other processes
that are particularly effective at the contemplation stage include decisional balance - how a
person evaluates and decides whether to adopt change - and self-efficacy. The TMC framework
conceptualizes self-efficacy as both confidence and temptation, thus a person who has high
confidence in their ability to resist temptation is considered to have resilient self-efficacy
(DiClemente et al., 2013; Glanz & Bishop, 2010).
Transtheoretical Model of Change and Current Study. Application of TMC theory to
this research could align mode of prediabetes diagnosis as factors that influence a process of
change specific to stage levels and/or to the techniques prescribed for each process. The DPP
program curriculum may support stage movement through self-efficacy as the participant gains
new confidence in the program. A prediabetes diagnosis, regardless of mode—clinical or selftest—could facilitate consciousness-raising if it enhances the awareness of health risk and
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external factors. In addition, cues to action from promotional messaging, social interactions, and
prior knowledge could affect the decisional balance to adopt change.
If the person has clinical diagnosis of prediabetes, their perception of self-efficacy could
be dependent on their understanding of the elements of the DPP at that time of the diagnosis as
well as the knowledge and attitude of the medical provider towards the program. The
information shared by the provider may not move the patient toward adoption of new behavior
because it does not support the process needed for the patient’s current stage of change. Or, they
may have experienced fear about the serious side effects associated with diabetes, then felt relief
when they learned that DPP is available as effective prevention. This process of dramatic relief
can be influential in moving a person from contemplation stage to preparation stage for new
behavior.
If an individual completes a self-assessment for risk test as a prerequisite to participation,
they may be in the contemplation of new behavior stage and the self-assessment may provide
new information that informs their decisional balance and moves them into preparation stage.
Or, they may already be in a preparation stage, with intention to adopt new behavior in the
immediate future. In order to move to the next stage— action— they may require new skills and
resources which could be learned as they go through the DPP curriculum.
Social Cognitive Theory
Program planners may use a multilevel intervention strategy that includes messaging
aimed at the population level in order to motivate the practice of positive health behaviors, or
influence perceptions that will move people away from negative behaviors. The Social Cognitive
Theory (SCT) developed by Bandura (1986) suggests that behavior is learned by observation and
imitation of the behavior exhibited by other people, as well as observation of an expected
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outcome from the behavior (Bandura,1986). This reciprocal relationship between an individual,
their behavior, and their environment influences motivation and ability to adopt new behaviors.
The key constructs of SCT are knowledge, perceived self-efficacy, outcome expectations, goal
formation, and sociostructural factors. (DiClemente et al, 2013: Glanz & Bishop, 2010).
Social Cognitive Theory and Current Study. Application of SCT to this research is
challenging as the constructs that influenced participation in DPP as a result of the prediabetes
diagnosis will in turn influence new behavior expectations and the environment of the other
participants in the DPP group. The prediabetes diagnosis regardless of mode—clinical or selftest—is likely influenced by the sociostructural factors in the individual’s environment. If their
environment and social interactions include people who model diabetes prevention behaviors
(and have experienced expected outcomes from DPP) their behavior actions may be influenced
by the collective self-efficacy in their environment.
If a person receives a clinical diagnosis of prediabetes they may not have any awareness
of expected prevention-related behaviors or have opportunity to become knowledgeable about
behaviors. SCT is like other theoretical applications to this research, in that individual
perceptions and attitudes related to the expected outcomes can be influenced by the provider who
provided the diagnosis. The patient’s perception of self-efficacy and ability to set goals related to
behavior change could be influenced by the medical provider’s attitude and knowledge of DPP.
If an individual completes a self-assessment for risk test as a prerequisite to participation
in DPP the person may already know about the program and an expectation of outcomes that
could be obtained through participation. They may also have a greater prevention self-efficacy;
the ability to exert control over their motivations, behavior, and social environment.
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Diffusion of Innovation Theory
Diffusion of Innovation Theory (DIT) is a social participatory model developed by
Everett Rogers (2014) comprised of four primary concepts of innovation, communication, social,
and time, that explain the way novel ideas (innovation) diffuse into social practices within a
population to create new behavioral norms. Innovation is defined as an idea, practice, or concept
that is perceived as new or novel to a population. The premise is that societal modeling of new
behaviors will promote increased adoption of those behaviors. Like other stages of change
models, individuals move through levels before the behavior becomes diffused: awareness,
decision to adopt or reject innovation, initial exploration, and continued use or practice of the
behavior. Individuals will consider factors like the relative advantage of the behavior,
compatibility with their values and experience, whether there is opportunity to try the behavior
without commitment, ability to discontinue the behavior, and whether the results are tangible
prior to adoption of the behavior. As individuals begin adoption, they may consider the
complexity of new behavior and the time commitment. Factors of commitment, modifiability,
and observability of the results are usually considered after the innovation has been adopted
(DiClemente et al, 2013; Rimer et al., 2005; Rogers, 2014).
Public health application has typically focused on using the DIT framework to facilitate
adoption of preventative health behavior in specific population groups. Successful adoption of
HIV/AIDS prevention behavior in San Francisco during the 1980’s AIDS epidemic has been
attributed to use of interventions based on innovation theory (Bertrand, 2004). Similarly, a
smoking cessation program modeled on innovation used multiple communication channels to
increase awareness and positioned primary care physicians as influencers to change the
normative behaviors and attitudes towards tobacco use (McManus, 2013)
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Diffusion of Innovation and Current Study. Application of DIT to this research
considers how the two types of prediabetes diagnosis may work as predictors to adopting an
innovation - participation in the DPP.
If a person has received a clinical diagnosis of prediabetes, it can be assumed that they
are either unaware of the DPP, or at a stage of awareness about the program through
communication. Research shows successful outcomes from positioning primary care physicians
as influencers to change normative behaviors and attitudes towards behavior change (McManus,
2013). Their ability to adopt the expected behavior may also be dependent on their interpretation
of the complexity of the program and the time commitment.
If an individual completes a self-assessment for risk test as a prerequisite to participation
in DPP they may be at the decision to adopt or reject innovation stage, or the initial exploration
stage. They may be influenced by communication about the program within their social realm or
by interaction with an innovator or early adopter. This person could benefit from the SCT-based
DPP curriculum as facilitators affirm the advantage of the program (prevention of diabetes), the
opportunity for tangible results (weight loss), and emphasize compatibility regarding how the
program is designed to help everyone modify behaviors based on their lifestyle.
The Current Study
The research aim of this study was to explore the association between mode of
prediabetes diagnosis—clinical blood test or self-risk assessment—on measured DPP outcomes
of attendance, physical activity minutes, percentage of weight loss, and combined goal
achievement of all three measures.
A number of common themes and assumptions were identified prior to the application of
the theoretical frameworks to understand the ways that the method of diagnosis may influence
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these outcomes. The assumed scenarios could indicate that the individual who completes a selfassessment for risk test is at a more advanced stage of readiness for change than the person who
receives a clinical diagnosis. Research indicates that early success with outcomes of weight loss
and physical activity are a predictor for retention in the DPP and increased outcomes are
associated with how long the individual is in the program. (Cannon et al., 2020; Ely et al., 2017;
Jeffers et al., 2019). Therefore, they may be more likely to implement the behavioral
modifications promoted in the DPP curriculum and be more receptive to the influence of
elements of SCT curriculum in the DPP. This movement towards behavior change at the
beginning of the program could influence the likelihood of early success and retention in the
program. Evidence shows increased positive outcomes associated with how long the individual is
in the program (Ely et al., 2017; Jeffers et al., 2019).
The first hypothesis proposes that participants who use a self-risk assessment to
determine their diabetes risk will attend a greater median number of sessions than participants
with clinical diagnosis of prediabetes. The second hypothesis states that participants who use a
self-risk assessment will also have greater median weekly physical activity minutes as of session
16 than those with clinical diagnoses. A third hypothesis states that participants use a self-risk
assessment to determine diabetes risk have greater median percentage of weight loss than those
with clinical diagnosis of prediabetes. The final hypothesis combines the goal outcomes of the
program and claims that the number of participants who use self-assessment to determine
diabetes risk and who achieve goal completion measures for attendance, physical activity, and
percentage of weight loss is greater than participants with a clinical diagnosis of prediabetes who
also achieve goal completion measures.
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CHAPTER III
RESEARCH METHODOLOGY
Study Design
This research study was a secondary data analysis utilizing a quantitative nonexperimental, cross-sectional design to investigate association between method of diagnosis of
prediabetes—clinical blood test or self-risk assessment—and DPP outcomes.
Procedures
This research used archival data from adults enrolled in a Diabetes Prevention Program
(DPP) from 2017 to 2020 at Virginia Mason Memorial in Yakima Washington. Participants were
eligible to enroll upon attendance of an orientation session and completion of required intake
document. Variable information includes participant enrollment source, payer type, participant’s
age, ethnicity, sex, height, education attainment, and prediabetes determination category. The
prediabetes categories are clinical test, previous GDM, or self-risk assessment. Measures for
clinical blood tests are either FG of 100 to 125 mg/dl, OGTT of 140 to 199 mg/dl, or A1c
measure of 5.7% to 6.4%. Self-risk assessment is a positive screening for prediabetes risk using
the ADA/CDC Prediabetes Risk Test (Figure 1).
Program facilitators weighed participants before each session and recorded weight
measures starting week 1 and participant-reported measures of physical activity (PA) minutes
starting week 6. Data were entered into a secure reporting system by the facilitator or DPP
coordinator, and the de-identified data were submitted bi-yearly to the CDC per agreement as a
CDC-recognized organization. Participants were included in this study if they attended at least
one DPP session delivered by VMM and data was collected for the outcomes of PA and weight
loss. The estimated total sample size was 1400 participants based on preliminary VMM program
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enrollment data (2020) from 2017 to 2020; however, a number of participant files could not be
retrieved and the number was reduced to 865 for analysis. An additional 72 records were
removed due to duplication, or abnormalities in the data that could not be resolved. As shown in
Figure 2, the final sample used for analysis was 793 participants, and 46.7% (n = 370) of
participants qualify for DPP by clinical test or GDM, and 53.3% (n = 423) completed self-test.
Figure 2
Consort Flow Diagram

Assessed for inclusion in study research
(N = 865)


→

Excluded due to data errors
and duplication (n = 72)


Analyzed (N = 793)

Group 1: Clinical Test
(n = 370)


Group 2: Self-Risk Test
(n = 423)

Sample Population
The demographic profile of study participants (N = 793) shown in Table 1, was 25% male
(n = 201, 75% female (n = 592), aged 18 to 94 (𝑥 60, 𝑥̃ 63). The racial and ethnic identity
distribution was 83.6% White (n = 663), 14.8% Hispanic or Latino (n = 117), 1.5% American
Indian or Alaska Native (n = 12), and 0.1% Other racial/ethnic identity which includes: Asian,
Black, or African American, and Native Hawaiian or Other Pacific Islander. Group 1 (n = 370)
included participants who were eligible for the DPP based on laboratory blood test (clinical test)
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or previously diagnosed GDM. The Group included 37% male (n = 137), 63% female (n = 233),
aged 18 to 84 (𝑥 59, 𝑥̃ 61). The racial and ethnic identity distribution was 82.4% White, 16.2%
Hispanic or Latino, 1.4% American Indian or Alaska Native. Group 2 (n = 423), includes
participants who had a positive screening for prediabetes risk using the ADA/CDC Prediabetes
Risk Test (Figure 1). Group 2 was 15% male (n = 64), 85% female (n = 359), aged 27 to 94 (𝑥
62, 𝑥̃ 64). The racial and ethnic identity distribution was 84.6% White, 13.5% Hispanic or
Latino, 1.5% American Indian or Alaska Native.
Table 1
Demographic Profile of Study Participants
Variables

Group 1 Clinical
Test (n = 370)

Group 2 Self-Test
(n = 423)

Full Study Sample
(N = 793)

n

%

n

%

n

%

Male

137

37

64

15

201

25

Female

233

63

359

85

592

75

Gender

Age
Mean

59

62

60

Median

61

64

63

Range

18-84

27-94

18-94

Racial/Ethnic
White

305

82.4

358

84.6

663

83.6

Hispanic or Latino
American Indian or Alaska
Native

60

16.2

57

13.5

117

14.8

5

1.4

7

1.7

12

1.5

Other racial/ethnic identity

2

0.05

1

0.02

1

0.4

Note. Other racial/ethnic identity includes: Asian, Black, or African American, and Native Hawaiian
or Other Pacific Islander.
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Preparation of Data
This research used a password-protected Microsoft Excel worksheet for management and
analysis of the de-identified data. Raw data was organized to allow for identification of
abnormalities in the data and statistical analysis of variables. Outliers and presumed data errors
were fact-checked and verified by the program coordinator before inclusion in this research. A
standard protocol for estimating missing data for measures of PA and weight loss was
implemented. If participants missed one session (>6 <17) mean PA minutes from the two closest
measures were entered for that date (609 missing data records [weeks 7-16] used estimated data).
Participants who missed 2> consecutive sessions were documented as zero for the missing dates.
Mean WL data was used for participants who missed session 16 but attended sessions 15 and 17.
There were 37 entries with estimated weight loss.
Statistical Analysis
This research places the method of diagnosis for prediabetes, clinical test or self-test, as
dichotomous independent variables and the median attendance, weekly PA, and WL% as
dependent variables.
The independent variable (IV) was categorical with two Groups as shown in Figure 2.
Group 1 (clinical test) includes participants who were eligible for the DPP based on laboratory
blood tests within the past year, or previously diagnosed GDM. Group 2 (self-test) includes
participants who had a positive screening for prediabetes risk using the ADA/CDC Prediabetes
Risk Test (Figure 1).
Participants in both Groups were measured on dependent variable (DV) outcomes of 1)
attendance, 2) PA, 3) percentage of weight loss (WL%), and 4) achievement of program goal
outcomes for attendance, PA, and WL%. Table 2 shows the DV for attendance of weekly
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sessions was measured as continuous interval data of the number attended (>1, <17). The DV for
self-reported PA minutes per week was proposed as a categorical score based on continuous
interval data of weekly PA minutes (>6, <17). 0= zero weekly PA minutes, 1= >0 to <59, 2= >60
to <150, 3= ≥151. This was proposed to reduce the range of distribution in the data. However,
the method was changed to measure PA minute as continuous interval median data when
analysis revealed non-parametric data and similar results. In addition, this measure aligns with
DPP program goal outcomes of 150 mean PA minutes per week. The weight loss DV was
measured as continuous interval data using percentage of WL from the starting weight through
the highest attended session (>1, <17). The goal completion outcomes DV was based on the
NDPP recommended outcomes to achieve maximum diabetes risk reduction: ≥16 weeks of
session attendance, ≥150 mean weekly PA minutes, and >5% weight loss. The goal completion
DV was measured using a discrete-binary variable (>16). 0= attendance <16, PA <150, and
WL% <5%. 1= attendance ≥16, PA ≥150, and WL% ≥5%.
The data analysis ToolPak in Microsoft Excel (2016) was used to perform data analysis
unless otherwise indicated. Dependent variable mean and median were assessed visually using
Box and Whisker graphs, and statistical analysis used Skewness and Kurtosis measures to
calculate departure from normality, and Kolmogorov-Smirnov (KS) calculator (Smirnov, 1948;
AAT Bioquest, 2021) to determine variance (normalcy) of data. The variables for attendance, PA
minutes, and WL% were asymmetrical (non-parametric) thus the Wilcoxon Mann-Whitney U test
(Mann, & Whitney, 1947; Social Science Statistics, n.d.) was used to compare median outcomes.
The alpha significance level of 0.5 was used for the 2-tailed hypothesis analysis. A z test for
proportions was used for analysis for the binary variable for goal completion (Social Science
Statistics, n.d.).

36

Table 2
Study Measures and Statistical Analysis
Dependent Variable

Statistical analysis
Non-parametric
Normalcy test of data
(Median data)

Data Measure

Hypothesis 1:
Attendance

Continuous interval data
(<1,<17)

Hypothesis 2:
Physical Activity
Minutes

Continuous interval data
(<6,<17)

Hypothesis 3:
Percent of weight
loss

Continuous interval data
(<1,<17)

Hypothesis 4:
Goal outcome
attainment

Discrete binary variable:
0= Attendance <16, PA
<150, and WL% <5.%.
1= Attendance ≥16, PA
≥150, and WL% ≥5.%.

Visual analysis:
Box and Whiskers
graph
Statistical analysis:
Skewness and Kurtosis
measures
Kolmogorov-Smirnov
(KS) calculator

n/a

Wilcoxon MannWhitney U Test = 0.5
alpha level

z test for proportions

Note. The DV for participant self-reported PA minutes was proposed for research as a categorical
score based on continuous interval data of weekly PA minutes reduce the range of normalcy. The
method of analysis was changed to measure PA minute as continuous interval median data when
analysis revealed non-parametric data and similar statistical results. In addition, this measure aligns
more closely with the DPP program goal outcome of 150 mean PA minutes per week.
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CHAPTER IV
RESULTS
The research aim of this study was to explore the association between mode of
prediabetes diagnosis—clinical blood test or self-risk assessment—on measured DPP outcomes
of attendance, physical activity minutes, percentage of weight loss, and combined goal
achievement of all three measures.
Hypothesis 1: Participants with DPP eligibility using self-assessment to determine
diabetes risk attend a greater median number of sessions (>1, <17) than participants with clinical
diagnosis of prediabetes. μ Self-test > μ Clinical
The evaluation of attendance measures (Table 3) revealed that all participants achieved
median attendance of 13 sessions; however, the calculation for Group 1 (clinical test) showed a
higher average rank mean (416) than Group 2 (self-test) rank mean of 380. This indicates
increased attendance values for those with a clinical diagnosis as a whole. The results were
significant (p < .0251) but did not support the directional hypothesis. Participants who had a
clinical diagnosis of prediabetes achieved increased outcomes of attendance in the DPP.
Hypothesis 2: Participants with DPP eligibility using self-assessment to determine
diabetes risk have greater median weekly physical activity minutes (>6, <17) than those with
clinical diagnosis of prediabetes. μ Self-test > μ Clinical
Group 1 (clinical diagnosis) achieved higher median self-reported minutes of physical
activity (𝑥̃ =110, mean rank 414) compared with Group 2 who completed the self-risk test
(𝑥̃ =90, mean rank 382). The results shown in Table 3 were significant (p < .049) and did not
support the directional hypothesis. Participants who had a clinical diagnosis of prediabetes
reported more minutes of weekly physical activity.
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Hypothesis 3: Participants with DPP eligibility using self-assessment to determine
diabetes risk have greater median percentage of weight loss (>1, <17) than those with clinical
diagnosis of prediabetes. μ Self-test > μ Clinical
Table 3 shows no significant differences in the measures for percentage of weight loss
between the clinical diagnosis Group 1 (𝑥̃ =.051, mean rank 402), and the self-risk test Group 2
(𝑥̃ =.048, mean rank 393). The results failed to reject the null hypothesis (p < .610).
Hypothesis 4: The number of participants with DPP eligibility using self-assessment to
determine diabetes risk who achieve goal completion outcomes of attendance ≥16 weeks, median
weekly physical activity ≥ 150 minutes, and percentage of weight loss ≥ 5% is greater than
participants with a clinical diagnosis of prediabetes who achieve goal completion. μ Self-test > μ
Clinical
The measures of goal completion in Table 4 show less than 5% (n = 38, 4.79%) of the
study participants (N = 793) completed the DPP goal completion outcomes of 16 weeks of
attendance, 150 median minutes of physical activity, and 5% weight loss. The largest proportion
(n =24, p̂ =.0649) were participants from Group 1 versus participants from Group 2 (n =14, p̂
=.0331). This was a significant result (p < .018) that rejected the null hypothesis that the sample
portions are equal and supports that more participants with a clinical diagnosis of prediabetes
achieved all of the goal outcomes of attendance in the DPP.
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Table 3
Statistical Results for Measures of Attendance, Physical Activity, and % of Weight Loss

Statistical Measure

Physical Activity
Minutes

Attendance

% of Weight Loss

Group 1:
Clinical
Test

Group 2:
Self Risk
Test

Group 1:
Clinical
Test

Group 2:
Self Risk
Test

Group 1:
Clinical
Test

Group 2:
Self Risk
Test

Median

13

13

110

90

0.051

0.048

Range

15

15

998

997

0.210

0.238

Mean of Ranks

416

380

414

382

402

393

Sample Mean of
Ranks

397

397

397

p-value

0.025

0.049

0.610

U-value

71062

71905

76608

Z -score

-2.23506

-1.97294

-0.51165

r value

0.99

0.91

0.99

Result is significant
at p < .05.
Rejects Null
Hypothesis

Result is NOT
significant
at p < .05.
Accepts Null
Hypothesis

Result is significant
at p < .05.
Rejects Null
Hypothesis

Table 4
Statistical Results for Measures of Goal Outcome Achievement
Statistical
Measure
Proportion
CL (95%)
Z -value
p value

Goal Achievement
Group 1: Clinical Test

Group 2: Self Risk Test

0.0649
0.0438-0.0859

0.0331
0.0188 - 0.0474

2.0894
0.018
Result is significant at p < .05. Rejects Null Hypothesis
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CHAPTER V
DISCUSSION
Diabetes is an irreversible, chronic disease that is estimated to affect 1 in 6 adults in the
United States by the year 2060. Diabetes will continue to have a negative impact on health,
quality of life, and the economy unless the incidence rate is decreased. There is no known cure
for diabetes, so prevention is the preferred medical action at the prediabetes stage. Clinical trials
support that behavior modification techniques resulting in weight loss and increased physical
activity are effective in preventing or delaying the development of diabetes. The DPP is a
valuable program for behavioral change, but many participants struggle to adopt lifestyle
modifications necessary to achieve the outcomes of the class. Many of the barriers to behavioral
change are factors that could be influenced by increased awareness, motivation, perception of
individual ability and likelihood of success, and attitudes of the people who hold positions of
influence in a person’s life.
As identified in the introduction, despite general awareness of the health threat associated
with diabetes, and evidence to support effective intervention at the prediabetes stage, many
individuals with prediabetes do not make or sustain modifications to behavior that will lower
their risk. In order to minimize incidence and prevalence of type 2 diabetes, it was critical to
assess possible factors that influence individual motivation to engage in risk reduction behaviors.
This research focused on a moment in time when the threat of developing diabetes became a
reality for many people regardless of their mode of prediabetes diagnosis. Since the data
available for analysis was gathered from a diabetes prevention program, it could be assumed that
the clinical diagnosis or confirmation of risk based on the self-test was a driving force for
participation in the program. The research aim of this study was to explore associations in that
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relationship. Specifically, whether one method of prediabetes diagnosis is associated with greater
outcomes from the program, measured by attendance, physical activity minutes, and weight loss.
The main study findings were that the group of people who had a clinical diagnosis of
prediabetes had greater measures of attendance, physical activity, and measures of goal
completion than the group of people who completed a self-risk assessment to determine diabetes
risk. The study measures for percentage of weight loss indicated that there was no significant
difference between the Groups.
The development of the directional hypothesis for this research was based on study of
theoretical frameworks that influence behavior change and how they could be applied to
individuals based on their mode of diagnosis. As shared at the beginning of that section, several
assumptions were used to rationalize the possible behavior of individuals before participation in
DPP.
It was presumed that when a person receives a clinical diagnosis of prediabetes that they
are unaware of their condition, and they will be greatly influenced by the health professional that
delivers the diagnosis. Their initial perceptions may be influenced by the attitude, perceptions,
and knowledge of the provider as it relates to diabetes risk. It was also assumed that they were in
a state of receiving information rather than actively seeking a diagnosis or confirmation of health
threat. Because of the demographic makeup of individuals in the program, it was assumed that
they have a relationship with their provider and would likely have contact with them at some
point during the program.
Because enrollment in the DPP program requires either a clinical diagnosis of prediabetes
or a self-assessment test that confirms risk of diabetes, it was assumed that intent to participate in
the program was the primary reason for self-assessment of risk. The risk test has been promoted

42

extensively in the Yakima Valley in conjunction with messaging about diabetes risk and Virginia
Mason Memorial community health events. Attendees at the DPP informational/orientation
meeting are given an opportunity to take the assessment if they want to enrollment in the class. If
an individual completes a risk test as a prerequisite to participation in DPP, it could be presumed
that they were aware of the prevention program and have a perception of the value of
participation in the program. It could also be assumed that they are in a state of seeking
information. If they completed the test after attending orientation, it could be assumed that it was
their decision to attend the orientation, perhaps with the intention to enroll, prior to receiving
information about the program. It can be expected that the individual used critical thinking and
honest assessment when they completed the risk test and in a state of prediabetes.
Research indicates that early success with outcomes of weight loss and physical activity
are a predictor for retention in the DPP and increased outcomes are associated with how long the
individual is in the program. (Cannon et al., 2020; Ely et al., 2017; Jeffers et al., 2019). The
assumed scenarios could indicate that the individual who completes a self-assessment for risk
test is at a more advanced stage of readiness for change than the person who receives a clinical
diagnosis. If they attended the orientation session, their perception of gain from behavior change
will likely be influenced by the testimonial of prior participants and the information shared. They
may be more readily influenced by positive communication about the program within their social
circle. This person could benefit from the SCT-based DPP curriculum as facilitators affirm the
advantage of the program (prevention of diabetes), the opportunity for tangible results (weight
loss), and emphasize compatibility regarding how the program is designed to help individuals
modify behaviors based on their lifestyle. Therefore, the premise of the directional hypothesis
was that participants who complete self-assessment test would be more likely to implement the
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behavioral modifications at the beginning of the program, which would influence the likelihood
of early success as well as retention, which would lead to increased outcomes from the program.
This choice of hypothesis direction was based on a variety of assumptions about both of
the methods of diagnosis. Many of the presumed scenarios for those who receive a clinical
diagnosis were also considered influential for positive behavior change in DPP.
For example, providers who routinely refer to the diabetes prevention program have
access to health education materials and resources developed specifically for promotion of DPP.
These resources can be beneficial in influencing the perception of favorable attitudes and
expectations related to behavioral change and move patients towards intent to engage in health
prevention behavior as described in the literature review on Theory of Planned Behavior. The
patient/provider relationship may have the most influence within the framework of the Health
Belief Model. Patients may experience increased perception of susceptibility and severity of
disease due to the tangible element of a clinical test and knowledge from a medical professional.
Ethical Considerations and Limitations
Ethical considerations for this study are minimal due to the observational nature of the
data. A letter of cooperation for data sharing was obtained from VMM, and exempt status was
granted from Human Subjects Research Council at Central Washington University.
Threats to validity may include data collection errors and facilitator bias. Data collection
errors related to weight loss may occur during the collection and preliminary documentation of
the measures taken at each session. Participants are requested to wear similar clothing each week
and remove their shoes for weighing, but the recommendation is not enforced. The facilitator
may misread the weight, or incorrectly document the data in the tracking sheet at the time, or
when entered into the VMM program, or the data may be misread if entered by another
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facilitator or the program coordinator. Weekly PA minutes are self-reported by participants
without evidence of intensity or duration and the same documentation errors may occur as with
the WL measures. There may be inconsistent methods for rounding fractional weight
measurements and weekly PA minutes up or down, and there may be unconscious bias to reward
or confirm expectations of the participants with higher weight loss results, or increased PA.
Participants may not attend every class, resulting in missing data for some weeks. These
threats were addressed by using Scatterplot and Standard deviation tests to determine outliers.
Data was cross-referenced and verified by the diabetes program coordinator at Virginia Mason
Memorial. A protocol was developed for estimating data that was missing from participant
records and the occurrence was included in the study results.
These threats to validity may be mitigated through increased oversight during the weight
data collection such as two-person validation at the time of collection. Other process
improvement steps could include immediate data entry into the VMM data program, or digital
scales networked to a data system to automatically record weight into a participant file.
Participant PA minutes could be measured using approved activity tracking devices and
documentation uploaded to a data system or printed out for manual data entry.
The study sample is not appropriate for generalization because it does not fully represent
the racial and ethnic profile of the community (see Table 2). In addition, the study participants
may be more likely to have a primary care provider, or medical home, because the program is
coordinated by a large health care organization affiliated with multiple family practice clinics in
Yakima Valley. The majority of physicians who refer patients to DPP are associated with this
healthcare system and have increased awareness of the program due to direct outreach and access
to referral mechanisms.
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The assumptions used in the theoretical analysis are limited to the sample and scope of
this study and do not reflect the needs of historically underrepresented populations or those
negatively affected by social determinates of health.
Implications for Further Research
The implications drawn from this study may provide valuable insight into the ways that
health behavior theory can be used to understand an individual’s possible reaction to a diagnosis
of disease. Further research is necessary to explore the assumptions that were considered to
understand ways that method of diagnosis may influence outcomes attained through DPP. The
assumptions may be valid; however, due to the historical nature of the data used in this study
they cannot be tested with reliability. Recommendations for further research involve robust
multi-point data collection to better understand and define the mechanisms that influence
individuals at the point of diagnosis by clinical testing, including identification of factors may
that prevent or deter those persons from participation.
There is opportunity for increased understanding of the factors that motivate people to
complete the self-risk test. Supplemental questions could identify if the assumption used in this
study—desire to attend DPP—is the most salient factor, or whether there are barriers to clinical
access and referral to the program. If participants identify that weight loss was the motivation,
(rather than diabetes prevention) it may indicate a need for effective WL programming in the
community.
Further research could also expand the statistical analysis of the data to measure
correlations between the participant variables, their mode of diagnosis, and the outcomes of the
program. Additional analysis could also reveal if there are patterns of retention based on goal
attainment as well as patterns of attrition that may correlate to specific lessons or activities.
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Conclusion
The National Diabetes Prevention Program is an effective way to decrease risk and
incidence of diabetes. Although the results of this study reflect the impact of secondary
prevention, they could be used to move intervention upstream to increase primary screening
procedures and referral with medical professionals. Practical application of the relative
association between clinical blood test and goal outcomes will inform health educators and
providers regarding potential for increased benefit from participation in DPP. Programmers may
see value in expansion of screening and streamlined referral methods to ensure access to clinical
diagnosis. Providers may explore methods of clinical referral outside of the primary care setting
such as dental or ophthalmology prescreening.
The association could also guide communication and marketing efforts to promote DPP
through patient interaction and support creation of educational materials for clinic use.
Additional resources may be put into position to aid in the transition from diagnosis to DPP
attendance. The results may influence physician attitudes regarding patient self-assessment and
provide new opportunity to analyze positive outcomes of LSM programming on population
health, regardless of prediabetes or diabetes risk status. In addition, the association may influence
coverage options for insurance and workplace health and wellness programs, as well as support
and funding for DPP on the County, State, and Federal policy levels.
Many health care organizations are severely impacted by medical care and associated
costs directed towards tertiary treatment of diabetes incidence. This has the potential to limit
their ability to offer prevention programming that will decrease risk of developing diabetes.
Therefore, strategies to increase effectiveness in diabetes prevention programming are of critical
importance and should continue to be the subject of public health research.
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APPENDIXES
Appendix A - Tables
Table 1
Demographic Profile of Study Participants
Variables

Group 1 Clinical
Test (n = 370)

Group 2 Self-Test
(n = 423)

Full Study Sample
(N = 793)

n

%

n

%

n

%

Male

137

37

64

15

201

25

Female

233

63

359

85

592

75

Gender

Age
Mean

59

62

60

Median

61

64

63

Range

18-84

27-94

18-94

Racial/Ethnic
White

305

82.4

358

84.6

663

83.6

Hispanic or Latino
American Indian or Alaska
Native

60

16.2

57

13.5

117

14.8

5

1.4

7

1.7

12

1.5

Other racial/ethnic identity

2

0.05

1

0.02

1

0.4

Note. Other racial/ethnic identity includes: Asian, Black, or African American, and Native Hawaiian
or Other Pacific Islander.
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Table 2
Study Measures and Statistical Analysis
Dependent Variable

Statistical analysis
Non-parametric
Normalcy test of data
(Median data)

Data Measure

Hypothesis 1:
Attendance

Continuous interval data
(<1,<17)

Hypothesis 2:
Physical Activity
Minutes

Continuous interval data
(<6,<17)

Hypothesis 3:
Percent of weight
loss

Continuous interval data
(<1,<17)

Hypothesis 4:
Goal outcome
attainment

Discrete binary variable:
0= Attendance <16, PA
<150, and WL% <5.%.
1= Attendance ≥16, PA
≥150, and WL% ≥5.%.

Visual analysis:
Box and Whiskers
graph
Statistical analysis:
Skewness and Kurtosis
measures
Kolmogorov-Smirnov
(KS) calculator

n/a

Wilcoxon MannWhitney U Test = 0.5
alpha level

z test for proportions

Note. The DV for participant self-reported PA minutes was proposed for research as a categorical
score based on continuous interval data of weekly PA minutes reduce the range of normalcy. The
method of analysis was changed to measure PA minute as continuous interval median data when
analysis revealed non-parametric data and similar statistical results. In addition, this measure aligns
more closely with the DPP program goal outcome of 150 mean PA minutes per week.
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Table 3
Statistical Results for Measures of Attendance, Physical Activity, and % of Weight Loss

Statistical Measure

Physical Activity
Minutes

Attendance

% of Weight Loss

Group 1:
Clinical
Test

Group 2:
Self Risk
Test

Group 1:
Clinical
Test

Group 2:
Self Risk
Test

Group 1:
Clinical
Test

Group 2:
Self Risk
Test

Median

13

13

110

90

0.051

0.048

Range

15

15

998

997

0.210

0.238

Mean of Ranks

416

380

414

382

402

393

Sample Mean of
Ranks

397

397

397

p-value

0.025

0.049

0.610

U-value

71062

71905

76608

Z -score

-2.23506

-1.97294

-0.51165

r value

0.99

0.91

0.99

Result is significant
at p < .05.
Rejects Null
Hypothesis

Result is NOT
significant
at p < .05.
Accepts Null
Hypothesis

Result is significant
at p < .05.
Rejects Null
Hypothesis

Table 4
Statistical Results for Measures of Goal Outcome Achievement
Statistical
Measure
Proportion
CL (95%)
Z -value
p value

Goal Achievement
Group 1: Clinical Test

Group 2: Self Risk Test

0.0649
0.0438-0.0859

0.0331
0.0188 - 0.0474

2.0894
0.018
Result is significant at p < .05. Rejects Null Hypothesis
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Appendix B – Figures
Figure 1
ADA/CDC Prediabetes Risk Test

Note. (https://www.cdc.gov/diabetes/prevention/pdf/Prediabetes-Risk-Test-Final.pdf). In the public domain.
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Figure 2
Consort Flow Diagram

Assessed for inclusion in study research
(N = 865)


→

Excluded due to data errors
and duplication (n = 72)


Analyzed (N = 793)

Group 1: Clinical Test
(n = 370)


Group 2: Self-Risk Test
(n = 423)
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Appendix C - List of Acronyms
A1c

Hemoglobin A1c

ADA

American Diabetes Association

BMI

Body mass index

CDC

Centers for Disease Control and Prevention

CI

Confidence interval

DIT

Diffusion of Innovation Theory

DPP

Diabetes prevention program

DPRP

Diabetes Prevention Recognition Program

FPG

Fasting plasma glucose

GDM

Gestational diabetes mellitus

HBM

Health Belief Model

HHS

Health & Human Services

LSM

Lifestyle Management

MDPP

Medicare Diabetes Prevention Program

NDPP

National Diabetes Prevention Program

NHIS

National Health Interview Study

NIDDK

National Institute of Diabetes and Digestive and Kidney Diseases

𝑥

Mean

𝑥̃

Median

OGTT

Oral glucose tolerance test

PA

Physical Activity

PCP

Primary Care Physician

SCT

Social Cognitive Theory

TMC

Transtheoretical Model of Change

TPB

Theory of Planned Behavior

TRA

Theory of Reasoned Action

VMM

Virginia Mason Memorial

WL%

Weight Loss Percentage
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